CN104147381B - Traditional Chinese medicine composition for treating hypertension and preparation method thereof - Google Patents
Traditional Chinese medicine composition for treating hypertension and preparation method thereof Download PDFInfo
- Publication number
- CN104147381B CN104147381B CN201410422325.9A CN201410422325A CN104147381B CN 104147381 B CN104147381 B CN 104147381B CN 201410422325 A CN201410422325 A CN 201410422325A CN 104147381 B CN104147381 B CN 104147381B
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- chinese medicine
- concentrated
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 96
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims description 15
- 239000009636 Huang Qi Substances 0.000 claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 112
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 50
- 241000628997 Flos Species 0.000 claims description 24
- 241000218628 Ginkgo Species 0.000 claims description 18
- 235000011201 Ginkgo Nutrition 0.000 claims description 18
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 17
- 230000006837 decompression Effects 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 16
- 230000001631 hypertensive effect Effects 0.000 claims description 16
- 238000004064 recycling Methods 0.000 claims description 16
- 239000000341 volatile oil Substances 0.000 claims description 16
- 239000008187 granular material Substances 0.000 claims description 14
- 235000019640 taste Nutrition 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000003826 tablet Substances 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 9
- 108010011485 Aspartame Proteins 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 8
- 229920001353 Dextrin Polymers 0.000 claims description 8
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 8
- 229960003438 aspartame Drugs 0.000 claims description 8
- 235000010357 aspartame Nutrition 0.000 claims description 8
- 239000000605 aspartame Substances 0.000 claims description 8
- 235000019425 dextrin Nutrition 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 5
- 229940126678 chinese medicines Drugs 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 abstract description 23
- 229940079593 drug Drugs 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 20
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 241000244355 Ligusticum Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 244000235659 Rubus idaeus Species 0.000 abstract 1
- 235000009122 Rubus idaeus Nutrition 0.000 abstract 1
- 241000124033 Salix Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 abstract 1
- 244000237330 gutta percha tree Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- 210000003734 kidney Anatomy 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 12
- 230000002496 gastric effect Effects 0.000 description 11
- 238000001802 infusion Methods 0.000 description 11
- 230000037396 body weight Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 230000002269 spontaneous effect Effects 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 6
- 229910052753 mercury Inorganic materials 0.000 description 6
- 239000003643 water by type Substances 0.000 description 6
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 230000002861 ventricular Effects 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical group COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000002837 heart atrium Anatomy 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000331528 Chlorophytum capense Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241001048935 Dendrobium chryseum Species 0.000 description 1
- 240000004638 Dendrobium nobile Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 244000237986 Melia azadirachta Species 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 201000004239 Secondary hypertension Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000304447 Sempervivum tectorum Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- -1 sublimed preparation Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicine and particularly relates to a traditional Chinese medicine composition for treating hypertension. The traditional Chinese medicine composition is prepared from following medicines: 5-9 parts of eucommia ulmoides, 8-15 parts of mulberry leaves, 12-18 parts of lycium barbarum, 10-20 parts of sophora flower buds, 8-16 parts of radix astragali, 5-15 parts of gingko leaves, 12-18 parts of ligusticum chuanxion, 15-25 parts of gardenia jasminoides, 5-15 parts of dendrobe, 5-10 parts of schisandra chinensis, 12-18 parts of salix leaves and 10-20 parts of rubus idaeus. The traditional Chinese medicine has a significant curative effect in reducing blood pressure without toxic and side effects.
Description
Technical field
The invention belongs to technical field of Chinese medicines, relate to a kind of Chinese medicine composition, more specifically relate to one and treat hypertensive Chinese medicine composition and preparation method thereof.
Background technology
The clinical syndrome that hypertension is is main manifestations with systemic arterial pressure rising, be divided into essential hypertension and secondary hypertension, China is hypertension big country, the health of the mankind in serious harm, therefore improve the understanding to hypertension, have extremely important meaning to early prevention, in time treatment.
The main harm of hypertension is the infringement of heart, brain, kidney, blood vessel, and the heart, brain, kidney, the vascular complication that cause thus.Want accomplish effectively to prevent and treat hypertension, just significantly can reduce incidence rate and the mortality rate of the complication caused by hypertension.Therefore, treating hypertensive main purpose is lower the death of cardiovascular and cerebrovascular disease and the danger of invalid (as paralysis etc.) to greatest extent, and reduces the generation of other complication.Now confirm, effectively control the incidence rate that blood pressure obviously can reduce cardiovascular and cerebrovascular vessel unexpected (myocardial infarction, cerebral infarction), lower mortality rate, extend the life of patient.
One for the treatment of hypertension target blood pressure will be dropped to arm's length standard.All hypertension all should be down to < 140/90 millimetres of mercury, and < 120/80 millimetres of mercury is even more ideal.If during the target organ damages such as hypertension complicated with diabetes mellitus or the heart, brain, kidney, should blood pressure be down to < 130/80 millimetres of mercury or reach desirable level, especially middle-young patients as far as possible.Simple systole hypertension (>=140/90 millimetres of mercury/< 90 millimetres of mercury), also can tune to < 90 millimetres of mercury.Two of target is the M & M reducing cardiovascular and cerebrovascular disease.Three of target reduces the infringement of target organ, causes the infringement of cardiovascular, cerebrovascular and kidney and other organs to be that hypertension controls bad immediate cause.Target organ will be protected in blood pressure lowering process.Four of target reduces poisonous side effect of medicine.Present people are particular about quality of life, get hold of the utilization of medicine, not affect orthobiosis for target.
On market, Chinese medicine Western medicine all has treatment hypertensive, but some medicine takes for a long time and loses blood pressure reduction, some medicines are it is desirable that long-term taking, patient creates dependency to medicine, and common hypertension Western medicine has side effect to health, and especially the side effect of reduction of blood pressure in high-speed medicine is larger, blood pressure of taking medicine then falls, refuse to obey and then rise, certain side effect must be produced to other parts of health in the course of time, and the share that the Western medicine of this blood pressure lowering commercially accounts for is very large.These treat hypertensive chemicals, although effect is fast, cure the symptoms, not the disease, side effect is more, also can produce medicine and rely on, for undesirable patient.
Hypertensive old complaint main cause is: blood, blood vessel, human body gene are impaired, and for impaired organ, it is required that blood circulation promoting and blood stasis dispelling, adjusting blood lipid, vessel softening, recovers the mechanism of regulation and control blood pressure, repairs human body gene defect.Adopt Chinese medicine to effect a permanent cure disease, have letter, just, the feature of honest and clean, effect, without toxicity, patient also takes like a shot.There are many taste medical instruments to have blood circulation promoting and blood stasis dispelling, adjusting blood lipid, vessel softening in Chinese medicinal material, recover the function of the mechanism of regulation and control blood pressure, reached the effect for the treatment of both the principal and secondary aspects of a disease by Chinese traditional treatment hypertension.
Summary of the invention
The invention discloses one and treat hypertensive Chinese medicine composition, this Chinese medicine composition good effect, side effect is little, is the Chinese medicine composition of a kind of safety, treating both the principal and secondary aspects of a disease.
The technical scheme adopted is: a kind of Chinese medicine composition, is made up of the raw material of following parts by weight: Cortex Eucommiae 5-9 part, Folium Mori 8-15 part, Fructus Lycii 12-18 part, Flos Sophorae Immaturus 10-20 part, Radix Astragali 8-16 part, Folium Ginkgo 5-15 part, Rhizoma Chuanxiong 12-18 part, Fructus Gardeniae 15-25 part, Herba Dendrobii 5-15 part, Fructus Schisandrae Chinensis 5-10 part, Folium Salicis Babylonicae 12-18 part, Fructus Rubi 10-20 part.
In Chinese medicine composition of the present invention, the Cortex Eucommiae, another name is thought celestial (" herbal classic "), wood is continuous, think secondary (" not Lu "), Mian (" Bencao Tujing "), Shi Sixian (" Amplification on Materia Medica addendum "), silk gross weight, silk neem bark (" Chinese medicinal herbal "), pull a skin (" Hunan medicine will "), silk flosssilk wadding skin (Soviet Union doctor " Chinese herbal medicine handbook ").Nature and flavor with return through: sweet, temperature.Return liver, kidney channel.Function with cure mainly: invigorating the liver and kidney, bone and muscle strengthening, antiabortive.For lumbago due to renal deficiency, muscles and bones is unable, blood leaking in gestation, frequent fetal movement; Hypertension.
Folium Mori, another name: bilobate, red leaves, Folium Mori, Herba adianti myriosori.Nature and flavor with return through: sweet, bitter, cold.Return lung, Liver Channel.Function with cure mainly: dispelling wind and heat pathogens, clearing away lung-heat and moistening for dryness, liver heat removing and eyesight improving.For anemopyretic cold, lung-heat type cough, dizziness headache, conjunctival congestion is dim-sighted.1) Folium Mori are good at loose wind heat and let out lung-heat, to affection due to external wind and heat, headache, cough etc., and the fit applications such as normal and Flos Chrysanthemi, Flos Lonicerae, Herba Menthae, Radix Peucedani, Radix Platycodonis.Folium Mori not only can be used for the conjunctival congestion photophobia that wind heat causes, and can clearing away liver-fire, to the conjunctival congestion and swelling pain of flaming up of liver-fire, can with the fit applications such as Flos Chrysanthemi, Semen Cassiae, Semen Plantaginis.As for deficiecny of liver-YIN, eyes is dim-sighted, and Folium Mori also can join Fructus Ligustri Lucidi, Fructus Lycii, the equivalent use of Semen Sesami Nigrum of nourishing the liver and kidney.2) Folium Mori are gently dispersed clearly, wind heat of faling apart, but effect is more weak.Clinical being mainly used in lets out clearly lung liver, as wind heat attacks lung, cough ant phlegm, or dryness-heat impairing the lung, dry cough without phlegm; And wind heat is attacked or the disease such as flaming up of liver-fire, conjunctival congestion and swelling pain, be conventional medicine.Join Fructus Arctii, Radix Peucedani, then loose wind lung heat clearing; Join Gypsum Fibrosum, Radix Ophiopogonis, then clearing away dryness lung moistening; Join Flos Chrysanthemi, Semen Cassiae, then liver heat removing and eyesight improving.
Fructus Lycii (formal name used at school: Lycium chinense) is the multi-branched shrub plant of Solanaceae Lycium, and high 0.5-1 rice, can reach more than 2 meters during cultivation.All there is distribution both at home and abroad.Fructus Lycii whole body is precious, and bright Li Shizhen (1518-1593 A.D.) Compendium of Material Medica is recorded: " spring adopts Folium Lycii, name sky essence grass; Summer picks flowers, name Sempervivum tectorum; Qiu Caizi, name Fructus Lycii; Dong Caigen, name Cortex Lycii ".Fructus Lycii tender leaf also known as Fructus Lycii head, edible or make Fructus Lycii tea.Modern study, Fructus Lycii has reduction blood glucose, lipotropy, and can antiatherogenic effect.
The Flos Sophorae Immaturus, another name: Bai Huai, Flos Citri grandis, character, alabastrum is avette or oval, and long 2 ~ 6mm, diameter is about 2mm.Calyx yellow green, several longitudinal grins are arranged at bottom.The top of calyx is the unopened petal of yellow-white.Bennet is tiny.Body is light, hands sth. made by twisting and broken.Odorless, mildly bitter flavor is puckery.Function cures mainly, flower (Flos Sophorae) cooling blood for hemostasis; Fruit (Fructus Sophorae) clearing away heat-fire.
The Radix Astragali have tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, inducing diuresis to remove edema, promote the production of body fluid nourish blood, row stagnant blood stasis dispelling, expelling pus and toxin by strengthening QI, expelling pus and promoting granulation effect.Folium Ginkgo, another name moth leaf, duck bottom sediment, nature and flavor are sweet, bitter, puckery, flat.GUIXIN, lung meridian.Function cures mainly, and astringes the lung, and relievings asthma, blood circulation promoting and blood stasis dispelling, pain relieving.For cough and asthma due to lung deficiency; Coronary heart disease, angina pectoris, hyperlipidemia.
The pungent temperature of Rhizoma Chuanxiong is fragrant dry, walks and does not keep, can go loose, and the up mountain peak that reaches is pushed up; Enter blood system again, descendingly reach the sea of blood.Blood circulation promoting and blood stasis dispelling effect is extensive, the suitable various disease of stagnation of blood stasis; Wind-expelling pain-stopping, effectiveness is excellent, can control the diseases such as wind syndrome of head headache, rheumatic arthralgia.
Fructus Gardeniae: sweet, bitter, cold.Return liver, gallbladder, stomach warp.Clearing away heat-damp and promoting diuresis, cooling blood for hemostasis.Main icterohepatitis, dysentery, cholecystitis, the high heat of flu, spits blood, epistaxis, urinary tract infection, oedema due to nephritis, mastitis, acute toothache, sore and toxic, traumatic injury.
Herba Dendrobii, another name: Lin Lan, taboo life, Du Lan, Dendrobium nobile Lindl flower, Qian Nianrun, Dendrobium denneanum Kerr., bracketplant.Nature and flavor with return through: sweet, be slightly cold.Return stomach, kidney channel.Function with cure mainly: reinforcing stomach reg fluid, nourishing YIN and clearing away heat.Lose for cloudy impairment of body fluid, xerostomia excessive thirst, lack of appetite is retched, deficiency-heat after being ill, poor vision.
Fructus Schisandrae Chinensis, is commonly called as Fructus Zanthoxyli Plansipini, sliding weight of steelyard, medicine Fructus Schisandrae Chinensis, face rattan, five Fructus Armeniacae Mumes etc., Tang etc. " Newly Revised Canon of Materia Medica " carry " the sweet acid of five tastes skin and flesh, arduous in core, have saline taste ", therefore have the name of Fructus Schisandrae Chinensis.Ancient medical book Cheng Ta Chi Zhu, profound and, meeting and, it is top grade to list in Sheng Nong's herbal classic the earliest, and herbal function is the power of strengthening by means of tonics, medical value is high, and it has astringes the lung, nourishing kidney, promote the production of body fluid, receive antiperspirant, effect of arresting seminal emission, clinically be mainly used in treatment and control the deficiency of the lung and breath with cough, xerostomia is done thirsty, spontaneous perspiration, night sweat, impairment caused by overstrain weakness and emaciation, emission, the diseases such as chronic diarrhea chronic dysentery.Modern pharmacology confirms, its extract has stronger hepatoprotective and sedation.
Folium Salicis Babylonicae is bitter, cold in nature; Return lung, kidney, heart channel; Function cures mainly: heat clearing away; Removing toxic substances; Diuresis; Suppressing the hyperactive liver; Pain relieving; Rash.Main chronic tracheitis; Urethritis; Cystitis; Vesical calculus; Nebulousurine; Hypertension; Swollen ulcer drug; Burn and scald; Arthralgia; Toothache; Acute diseases such as cholera and sunstroke rash; Skin pruritus.
Fructus Rubi, another name, covers basin, black Fischer, little pallet, Shan Pao, Jin Fischer; Nature and flavor: warm in nature, sweet in the mouth, acid.Return liver, kidney; Function cures mainly: the liver and the kidney tonifying, controlling nocturnal emission with astringent drugs reducing urination, improving eyesight.Main impotence and premature ejaculation, emission and spermatorrhea, cold womb is infertile, and leukorrhagia is rare clearly, frequent micturition incontinence of urine, and blurred vision is dark, early whitening of beard and hair.
The present invention treats hypertensive Chinese medicine and is mainly used in blood circulation promoting and blood stasis dispelling, and the method such as stasis-dispelling and pain-killing, removing damp-heat from the liver and the gallbladder is treated.After Chinese medicine composition combination of the present invention, there is significant blood pressure lowering effect.The parts by weight of the present invention to above-mentioned all taste Chinese medicine carry out preferably, preferred condition be after drug matching uses medicine to the enhancing for the treatment of antihypertensive effect.As a most preferred embodiment of the present invention, Chinese medicine composition of the present invention is made up of the raw material of following parts by weight: the Cortex Eucommiae 7 parts, 12 parts, Folium Mori, Fructus Lycii 16 parts, the Flos Sophorae Immaturus 15 parts, the Radix Astragali 12 parts, Folium Ginkgo 9 parts, Rhizoma Chuanxiong 16 parts, Fructus Gardeniae 20 parts, Herba Dendrobii 10 parts, Fructus Schisandrae Chinensis 8 parts, Folium Salicis Babylonicae 16 parts, Fructus Rubi 16 parts.
Present invention also offers a kind of preparation method of Chinese medicine composition described above, it mainly comprises following step: get the above-mentioned 12 taste Chinese crude drugs of recipe quantity, Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis add 150-300 weight parts water and extract to obtain volatile oil, and medicinal residues are for subsequent use, volatile oil when 45-65 DEG C by 5-9 weight portion beta-schardinger dextrin-inclusion, for subsequent use, it is 1.12 ~ 1.16 that remaining concentration of liquid medicine to 50 DEG C measures relative density, adds ethanol and makes alcohol content be 50%, medicinal residues and Folium Mori, Fructus Lycii, the Flos Sophorae Immaturus, the Radix Astragali, Folium Ginkgo, Folium Salicis Babylonicae, Fructus Rubi decocts with water secondary, add water 100-150 weight portion for the first time, decoct 1-3 hour, add water 80-150 weight portion for the second time, decoct 0.5-2 hour, collecting decoction, filter, concentrating under reduced pressure, pressure is-0.08Mpa, temperature is 45-75 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.12 ~ 1.16, let cool, adding ethanol makes alcohol content be 50%, leave standstill, filter, filtrate and above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, the alcohol liquid of Fructus Schisandrae Chinensis merges, decompression recycling ethanol, pressure is-0.08Mpa, temperature is 45-75 DEG C, be concentrated into 50 DEG C and measure relative density 1.12 ~ 1.16, the Cortex Eucommiae is separately decocted, decoct with water secondary, add water 80-200 weight portion for the first time, decocts 1-3 hour, add water 80-150 weight portion for the second time, decoct 0.5-2 hour, collecting decoction, filter, concentrating under reduced pressure, pressure is-0.08Mpa, and temperature is 45-75 DEG C, is concentrated into the clear paste that 50 DEG C measure relative density 1.12 ~ 1.16, let cool, adding ethanol makes alcohol content be 50%, leaves standstill, and filters, decompression filtrate recycling ethanol, pressure is-0.08Mpa, and temperature is 45-75 DEG C, is concentrated into 50 DEG C and measures relative density 1.12 ~ 1.16, merged by above-mentioned concentrated solution, stir evenly, mesh screen filters, concentrated, adds above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis clathrate, dextrin and aspartame, and mixing is granulated, and dry, granulate, namely available conventional formulation method makes clinical receptible various dosage form.
In order to express Chinese medicine composition of the present invention better, Chinese medicine composition of the present invention can be prepared into dosage form conventional clinically.Be preferably, powderous preparations, powder, pill, sublimed preparation, unguentum, granule, oral liquid, tablet, capsule etc.More preferably, Chinese medicine composition of the present invention conveniently preparation technology be prepared into granule, tablet or capsule.
Chinese medicine composition of the present invention is known by pharmacodynamics test, the therapeutic outcome of spontaneous hypertensive rat blood pressure is shown, in medicine of the present invention dosage group and heavy dose of group gastric infusion after 15 days with administration before and model control group comparing difference significantly (P<0.01); Medicine small dose group gastric infusion of the present invention after 15 days with compare before administration reduce blood pressure significantly (P<0.05), medicine small dose group gastric infusion of the present invention compares with model control group after 15 days reduce blood pressure more remarkable (P<0.01), and medicine small dose group gastric infusion of the present invention compares with model control group reduce blood pressure more remarkable (P<0.01) after 45 days with before administration.Simultaneously the present composition and Nifedipine group can effective reversing hypertension rat left chamber myocardial hypertrophies, and the heavy dose of group of the present invention is better than positive controls, this demonstrate that the treatment of Chinese medicine composition of the present invention to spontaneous hypertensive rat myocardial hypertrophy achieves good synergism.
In addition, Chinese medicine composition of the present invention is natural pure Chinese medicinal preparation, and untoward reaction and side effect significantly reduce, and Chinese medicine composition effect of the present invention is comprehensive, medication effect is better, significantly improves the compliance of hyperpietic, and improves the quality of life of patient.Raw material of Chinese medicine medicine compatibility of the present invention is reasonable, complements each other, well can treat hypertension.Chinese Traditional Herbs Drug Clinical Testing of the present invention treats 329 examples altogether, and total effective rate reaches 97.8%.Wherein criterion of therapeutical effect: recovery from illness: symptom all disappears, and blood pressure inspection is normal; Effective: symptom disappears substantially, diastolic pressure and systolic pressure obviously reduce; Invalid: symptom is not improved.Instructions of taking: take granule described in invention compositions embodiment 1 every day 1-2 time, serve on 3 months.To 329 hyperpietics, adopt Chinese medicine composition of the present invention to carry out and followed the tracks for the treatment of.Wherein, cure 310 examples, account for 94.2%; Effective 12 examples, account for 3.6%; Invalid 8 examples, account for 2.4%; Total effective rate is about 97.8%.
Detailed description of the invention
Further describe the present invention below by way of specific embodiment, the present invention is not limited only to following examples.Within the scope of the invention or not departing from content of the present invention, spirit and scope, the change carried out the present invention, combination or replacement, be apparent for a person skilled in the art, and be included within the scope of the present invention.
Embodiment 1 Chinese medicinal composition granules
Prescription: be made up of the raw material of following parts by weight: the Cortex Eucommiae 7 parts, 12 parts, Folium Mori, Fructus Lycii 16 parts, the Flos Sophorae Immaturus 15 parts, the Radix Astragali 12 parts, Folium Ginkgo 9 parts, Rhizoma Chuanxiong 16 parts, Fructus Gardeniae 20 parts, Herba Dendrobii 10 parts, Fructus Schisandrae Chinensis 8 parts, Folium Salicis Babylonicae 16 parts, Fructus Rubi 16 parts.
Preparation technology: get the above-mentioned 12 taste Chinese crude drugs of recipe quantity, Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis are added 220 weight parts waters and extract to obtain volatile oil, and medicinal residues are for subsequent use, volatile oil 55 DEG C time by 7 weight portion beta-schardinger dextrin-inclusions, for subsequent use, it is 1.13 ~ 1.15 that remaining concentration of liquid medicine to 50 DEG C measures relative density, adds ethanol and makes alcohol content be 50%, medicinal residues and Folium Mori, Fructus Lycii, the Flos Sophorae Immaturus, the Radix Astragali, Folium Ginkgo, Folium Salicis Babylonicae, Fructus Rubi decocts with water secondary, add water 120 weight portions for the first time, decoct 2 hours, add water 120 weight portions for the second time, decoct 1.5 hours, collecting decoction, filter, concentrating under reduced pressure, pressure is-0.08Mpa, temperature is 65 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.13 ~ 1.15, let cool, adding ethanol makes alcohol content be 50%, leave standstill, filter, filtrate and above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, the alcohol liquid of Fructus Schisandrae Chinensis merges, decompression recycling ethanol, pressure is-0.08Mpa, temperature is 65 DEG C, be concentrated into 50 DEG C and measure relative density 1.13 ~ 1.15, the Cortex Eucommiae is separately decocted, and decocts with water secondary, and add water 150 weight portions for the first time, decocts 2 hours, add water 120 weight portions for the second time, decocts 1.5 hours, collecting decoction, filters, concentrating under reduced pressure, pressure is-0.08Mpa, and temperature is 65 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.13 ~ 1.15, let cool, add ethanol and make alcohol content be 50%, leave standstill, filter, decompression filtrate recycling ethanol, pressure is-0.08Mpa, and temperature is 65 DEG C, is concentrated into 50 DEG C and measures relative density 1.13 ~ 1.15, merged by above-mentioned concentrated solution, stir evenly, mesh screen filters, concentrated, adds above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis clathrate, dextrin and aspartame, and mixing is granulated, and dry, granulate, makes granule by conventional formulation method.
The agent of embodiment 2 Chinese medicinal composition capsules
Prescription: be made up of the raw material of following parts by weight: the Cortex Eucommiae 5 parts, 8 parts, Folium Mori, Fructus Lycii 12 parts, the Flos Sophorae Immaturus 10 parts, the Radix Astragali 8 parts, Folium Ginkgo 5 parts, Rhizoma Chuanxiong 12 parts, Fructus Gardeniae 15 parts, Herba Dendrobii 5 parts, Fructus Schisandrae Chinensis 5 parts, Folium Salicis Babylonicae 12 parts, Fructus Rubi 10 parts.
Preparation technology: get the above-mentioned 12 taste Chinese crude drugs of recipe quantity, Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis are added 220 weight parts waters and extract to obtain volatile oil, and medicinal residues are for subsequent use, volatile oil 55 DEG C time by 7 weight portion beta-schardinger dextrin-inclusions, for subsequent use, it is 1.13 ~ 1.15 that remaining concentration of liquid medicine to 50 DEG C measures relative density, adds ethanol and makes alcohol content be 50%, medicinal residues and Folium Mori, Fructus Lycii, the Flos Sophorae Immaturus, the Radix Astragali, Folium Ginkgo, Folium Salicis Babylonicae, Fructus Rubi decocts with water secondary, add water 120 weight portions for the first time, decoct 2 hours, add water 120 weight portions for the second time, decoct 1.5 hours, collecting decoction, filter, concentrating under reduced pressure, pressure is-0.08Mpa, temperature is 65 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.13 ~ 1.15, let cool, adding ethanol makes alcohol content be 50%, leave standstill, filter, filtrate and above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, the alcohol liquid of Fructus Schisandrae Chinensis merges, decompression recycling ethanol, pressure is-0.08Mpa, temperature is 65 DEG C, be concentrated into 50 DEG C and measure relative density 1.13 ~ 1.15, the Cortex Eucommiae is separately decocted, and decocts with water secondary, and add water 150 weight portions for the first time, decocts 2 hours, add water 120 weight portions for the second time, decocts 1.5 hours, collecting decoction, filters, concentrating under reduced pressure, pressure is-0.08Mpa, and temperature is 65 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.13 ~ 1.15, let cool, add ethanol and make alcohol content be 50%, leave standstill, filter, decompression filtrate recycling ethanol, pressure is-0.08Mpa, and temperature is 65 DEG C, is concentrated into 50 DEG C and measures relative density 1.13 ~ 1.15, merged by above-mentioned concentrated solution, stir evenly, mesh screen filters, concentrated, adds above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis clathrate, dextrin and aspartame, and mixing is granulated, and dry, granulate, makes capsule by conventional formulation method.
Embodiment 3 Chinese medicine composition tablet
Prescription: be made up of the raw material of following parts by weight: the Cortex Eucommiae 9 parts, 15 parts, Folium Mori, Fructus Lycii 18 parts, the Flos Sophorae Immaturus 20 parts, the Radix Astragali 16 parts, Folium Ginkgo 15 parts, Rhizoma Chuanxiong 18 parts, Fructus Gardeniae 25 parts, Herba Dendrobii 15 parts, Fructus Schisandrae Chinensis 10 parts, Folium Salicis Babylonicae 18 parts, Fructus Rubi 20 parts.
Preparation technology: get the above-mentioned 12 taste Chinese crude drugs of recipe quantity, Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis are added 220 weight parts waters and extract to obtain volatile oil, and medicinal residues are for subsequent use, volatile oil 55 DEG C time by 7 weight portion beta-schardinger dextrin-inclusions, for subsequent use, it is 1.13 ~ 1.15 that remaining concentration of liquid medicine to 50 DEG C measures relative density, adds ethanol and makes alcohol content be 50%, medicinal residues and Folium Mori, Fructus Lycii, the Flos Sophorae Immaturus, the Radix Astragali, Folium Ginkgo, Folium Salicis Babylonicae, Fructus Rubi decocts with water secondary, add water 120 weight portions for the first time, decoct 2 hours, add water 120 weight portions for the second time, decoct 1.5 hours, collecting decoction, filter, concentrating under reduced pressure, pressure is-0.08Mpa, temperature is 65 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.13 ~ 1.15, let cool, adding ethanol makes alcohol content be 50%, leave standstill, filter, filtrate and above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, the alcohol liquid of Fructus Schisandrae Chinensis merges, decompression recycling ethanol, pressure is-0.08Mpa, temperature is 65 DEG C, be concentrated into 50 DEG C and measure relative density 1.13 ~ 1.15, the Cortex Eucommiae is separately decocted, and decocts with water secondary, and add water 150 weight portions for the first time, decocts 2 hours, add water 120 weight portions for the second time, decocts 1.5 hours, collecting decoction, filters, concentrating under reduced pressure, pressure is-0.08Mpa, and temperature is 65 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.13 ~ 1.15, let cool, add ethanol and make alcohol content be 50%, leave standstill, filter, decompression filtrate recycling ethanol, pressure is-0.08Mpa, and temperature is 65 DEG C, is concentrated into 50 DEG C and measures relative density 1.13 ~ 1.15, merged by above-mentioned concentrated solution, stir evenly, mesh screen filters, concentrated, adds above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis clathrate, dextrin and aspartame, and mixing is granulated, and dry, granulate, makes tablet by conventional formulation method.
Embodiment 4 Chinese medicine composition tablet
Prescription: be made up of the raw material of following parts by weight: the Cortex Eucommiae 5 parts, 15 parts, Folium Mori, Fructus Lycii 12 parts, the Flos Sophorae Immaturus 20 parts, the Radix Astragali 8 parts, Folium Ginkgo 15 parts, Rhizoma Chuanxiong 12 parts, Fructus Gardeniae 25 parts, Herba Dendrobii 5 parts, Fructus Schisandrae Chinensis 10 parts, Folium Salicis Babylonicae 12 parts, Fructus Rubi 20 parts.
Preparation technology: get the above-mentioned 12 taste Chinese crude drugs of recipe quantity, Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis add 150 weight parts waters and extract to obtain volatile oil, and medicinal residues are for subsequent use, volatile oil 45 DEG C time by 9 weight portion beta-schardinger dextrin-inclusions, for subsequent use, it is 1.12 ~ 1.14 that remaining concentration of liquid medicine to 50 DEG C measures relative density, adds ethanol and makes alcohol content be 50%, medicinal residues and Folium Mori, Fructus Lycii, the Flos Sophorae Immaturus, the Radix Astragali, Folium Ginkgo, Folium Salicis Babylonicae, Fructus Rubi decocts with water secondary, add water 100 weight portions for the first time, decoct 3 hours, add water 80 weight portions for the second time, decoct 2 hours, collecting decoction, filter, concentrating under reduced pressure, pressure is-0.08Mpa, temperature is 45 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.12 ~ 1.14, let cool, adding ethanol makes alcohol content be 50%, leave standstill, filter, filtrate and above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, the alcohol liquid of Fructus Schisandrae Chinensis merges, decompression recycling ethanol, pressure is-0.08Mpa, temperature is 45 DEG C, be concentrated into 50 DEG C and measure relative density 1.12 ~ 1.14, the Cortex Eucommiae is separately decocted, and decocts with water secondary, and add water 80 weight portions for the first time, decocts 3 hours, add water 80 weight portions for the second time, decocts 2 hours, collecting decoction, filters, concentrating under reduced pressure, pressure is-0.08Mpa, and temperature is 45 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.12 ~ 1.14, let cool, add ethanol and make alcohol content be 50%, leave standstill, filter, decompression filtrate recycling ethanol, pressure is-0.08Mpa, and temperature is 45 DEG C, is concentrated into 50 DEG C and measures relative density 1.12 ~ 1.14, merged by above-mentioned concentrated solution, stir evenly, mesh screen filters, concentrated, adds above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis clathrate, dextrin and aspartame, and mixing is granulated, and dry, granulate, makes tablet by conventional formulation method.
Embodiment 5 Chinese medicine composition tablet
Prescription: be made up of the raw material of following parts by weight: the Cortex Eucommiae 9 parts, 8 parts, Folium Mori, Fructus Lycii 18 parts, the Flos Sophorae Immaturus 10 parts, the Radix Astragali 16 parts, Folium Ginkgo 5 parts, Rhizoma Chuanxiong 18 parts, Fructus Gardeniae 15 parts, Herba Dendrobii 15 parts, Fructus Schisandrae Chinensis 5 parts, Folium Salicis Babylonicae 18 parts, Fructus Rubi 10 parts.
Preparation technology: get the above-mentioned 12 taste Chinese crude drugs of recipe quantity, Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis add 300 weight parts waters and extract to obtain volatile oil, and medicinal residues are for subsequent use, volatile oil 65 DEG C time by 5 weight portion beta-schardinger dextrin-inclusions, for subsequent use, it is 1.14 ~ 1.16 that remaining concentration of liquid medicine to 50 DEG C measures relative density, adds ethanol and makes alcohol content be 50%, medicinal residues and Folium Mori, Fructus Lycii, the Flos Sophorae Immaturus, the Radix Astragali, Folium Ginkgo, Folium Salicis Babylonicae, Fructus Rubi decocts with water secondary, add water 150 weight portions for the first time, decoct 1 hour, add water 150 weight portions for the second time, decoct 0.5 hour, collecting decoction, filter, concentrating under reduced pressure, pressure is-0.08Mpa, temperature is 75 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.14 ~ 1.16, let cool, adding ethanol makes alcohol content be 50%, leave standstill, filter, filtrate and above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, the alcohol liquid of Fructus Schisandrae Chinensis merges, decompression recycling ethanol, pressure is-0.08Mpa, temperature is 75 DEG C, be concentrated into 50 DEG C and measure relative density 1.14 ~ 1.16, the Cortex Eucommiae is separately decocted, and decocts with water secondary, and add water 200 weight portions for the first time, decocts 1 hour, add water 150 weight portions for the second time, decocts 0.5 hour, collecting decoction, filters, concentrating under reduced pressure, pressure is-0.08Mpa, and temperature is 75 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.14 ~ 1.16, let cool, add ethanol and make alcohol content be 50%, leave standstill, filter, decompression filtrate recycling ethanol, pressure is-0.08Mpa, and temperature is 75 DEG C, is concentrated into 50 DEG C and measures relative density 1.14 ~ 1.16, merged by above-mentioned concentrated solution, stir evenly, mesh screen filters, concentrated, adds above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis clathrate, dextrin and aspartame, and mixing is granulated, and dry, granulate, makes tablet by conventional formulation method.
Embodiment 6 Chinese medicine composition tablet
Prescription: be made up of the raw material of following parts by weight: the Cortex Eucommiae 9 parts, 15 parts, Folium Mori, Fructus Lycii 18 parts, the Flos Sophorae Immaturus 10 parts, the Radix Astragali 8 parts, Folium Ginkgo 5 parts, Rhizoma Chuanxiong 18 parts, Fructus Gardeniae 25 parts, Herba Dendrobii 5 parts, Fructus Schisandrae Chinensis 5 parts, Folium Salicis Babylonicae 12 parts, Fructus Rubi 10 parts.
Preparation technology: get the above-mentioned 12 taste Chinese crude drugs of recipe quantity, Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis add 300 weight parts waters and extract to obtain volatile oil, and medicinal residues are for subsequent use, volatile oil 60 DEG C time by 7 weight portion beta-schardinger dextrin-inclusions, for subsequent use, it is 1.13 ~ 1.15 that remaining concentration of liquid medicine to 50 DEG C measures relative density, adds ethanol and makes alcohol content be 50%, medicinal residues and Folium Mori, Fructus Lycii, the Flos Sophorae Immaturus, the Radix Astragali, Folium Ginkgo, Folium Salicis Babylonicae, Fructus Rubi decocts with water secondary, add water 110 weight portions for the first time, decoct 2.5 hours, add water 100 weight portions for the second time, decoct 1 hour, collecting decoction, filter, concentrating under reduced pressure, pressure is-0.08Mpa, temperature is 60 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.13 ~ 1.15, let cool, adding ethanol makes alcohol content be 50%, leave standstill, filter, filtrate and above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, the alcohol liquid of Fructus Schisandrae Chinensis merges, decompression recycling ethanol, pressure is-0.08Mpa, temperature is 60 DEG C, be concentrated into 50 DEG C and measure relative density 1.13 ~ 1.15, the Cortex Eucommiae is separately decocted, and decocts with water secondary, and add water 150 weight portions for the first time, decocts 1.5 hours, add water 100 weight portions for the second time, decocts 1.5 hours, collecting decoction, filters, concentrating under reduced pressure, pressure is-0.08Mpa, and temperature is 60 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.13 ~ 1.15, let cool, add ethanol and make alcohol content be 50%, leave standstill, filter, decompression filtrate recycling ethanol, pressure is-0.08Mpa, and temperature is 60 DEG C, is concentrated into 50 DEG C and measures relative density 1.13 ~ 1.15, merged by above-mentioned concentrated solution, stir evenly, mesh screen filters, concentrated, adds above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis clathrate, dextrin and aspartame, and mixing is granulated, and dry, granulate, makes tablet by conventional formulation method.
Embodiment 7: the pharmacodynamics test of Chinese medicine composition of the present invention
1. Chinese medicine composition of the present invention is on the impact of spontaneous hypertensive rat blood pressure
Spontaneous hypertensive rat 50, male and female half and half, body weight 300 ± 20g, five groups are divided at random by body weight, i.e. drug bolus group 40.0mg/kg of the present invention (Chinese medicine composition presses crude drug gauge), middle dosage group 20.0mg/kg (Chinese medicine composition is by crude drug gauge), small dose group 10.0mg/kg (Chinese medicine composition is by crude drug gauge), positive drug Nifedipine group 20mg/kg, model control group, often organizes 10.Gastric infusion volume is 1ml/200g, and model control group gives isopyknic 0.5% sodium carboxymethyl cellulose.
Each group is gastric infusion, once a day.In experimentation, observe animal diet followed, survival condition and behavioral activity every day, every day measures body weight, according to body weight adjustment drug dose.Put to death animal after 8 weeks, dirty survey left ventricular mass of coring, calculates left room index.
Temperature controls at 18 DEG C-22 DEG C, temperature 45%-65%, Indoor Natural light.With tail arterial blood pressure under BP-2006A intelligence non-invasive blood pressure measuring measurement rat waking state.Within 5th, 15,30 day, distinguish Measure blood pressure with method upon administration, all measure 5 times between 2 hours to 5 hours after gastric infusion, get the blood pressure of its average as this sample.
Result shows, in medicine of the present invention dosage group and heavy dose of group gastric infusion after 15 days with administration before and model control group comparing difference significantly (P<0.01).Medicine small dose group gastric infusion of the present invention after 15 days with compare before administration reduce blood pressure significantly (P<0.05), medicine small dose group gastric infusion of the present invention compares with model control group after 15 days reduce blood pressure more remarkable (P<0.01), and medicine small dose group gastric infusion of the present invention compares with model control group reduce blood pressure more remarkable (P<0.01) after 15 days with before administration.The results detailed in Table 1.
Table 1 medicine of the present invention on the impact of spontaneous hypertensive rat systolic blood pressure (mmHg) (
n=10)
Note: compared with before medicine,
*p<0.05,
*p<0.01; Compared with model group,
#p<0.05,
##p<0.01
2. cardiac weight, left ventricular mass, body weight and left ventricular hypertrophy index (left ventricular mass/body weight) measure:
With 10% potassium chloride (2mmol/L, 1ml/ is only) put to death rat after, survey body weight, take out heart, remove the outer connective tissue of atrium, trunk and heart, rinse well, filter paper blots rear removal atrium, claim left ventricular mass, calculate left ventricular hypertrophy index (left ventricular mass and body weight ratio), the results are shown in Table 2.
Table 2 hypertension compound recipe on the impact of spontaneous hypertensive rat myocardial hypertrophy (
n=10)
Note: compare with model group
*p < 0.05,
*p < 0.01; Compare with positive controls,
#p < 0.05,
##p < 0.01.
Result shows, contrast with model group, Chinese medicine composition of the present invention and Nifedipine group can effective reversing hypertension rat left chamber myocardial hypertrophies, and in the present invention, dosage group and heavy dose of group are better than positive controls, this demonstrate that the treatment of the present composition to spontaneous hypertensive rat myocardial hypertrophy achieves good synergism.
Claims (3)
1. the hypertensive Chinese medicine composition for the treatment of, it is characterized in that, it is made up of the raw material of following parts by weight: the Cortex Eucommiae 7 parts, 12 parts, Folium Mori, Fructus Lycii 16 parts, the Flos Sophorae Immaturus 15 parts, the Radix Astragali 12 parts, Folium Ginkgo 9 parts, Rhizoma Chuanxiong 16 parts, Fructus Gardeniae 20 parts, Herba Dendrobii 10 parts, Fructus Schisandrae Chinensis 8 parts, Folium Salicis Babylonicae 16 parts, Fructus Rubi 16 parts.
2. prepare a method for Chinese medicine composition as claimed in claim 1, it is characterized in that, it comprises the following steps:
In 12 taste Chinese medicines according to claim 1, Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis add 150-300 weight parts water and extract to obtain volatile oil, and medicinal residues are for subsequent use; Volatile oil when 45-65 DEG C by 5-9 weight portion beta-schardinger dextrin-inclusion, for subsequent use; It is 1.12 ~ 1.16 that remaining concentration of liquid medicine to 50 DEG C measures relative density, adds ethanol and makes alcohol content be 50%;
Medicinal residues and Folium Mori, Fructus Lycii, the Flos Sophorae Immaturus, the Radix Astragali, Folium Ginkgo, Folium Salicis Babylonicae, Fructus Rubi decocts with water secondary, add water 100-150 weight portion for the first time, decoct 1-3 hour, add water 80-150 weight portion for the second time, decoct 0.5-2 hour, collecting decoction, filter, concentrating under reduced pressure, pressure is-0.08Mpa, temperature is 45-75 DEG C, be concentrated into the clear paste that 50 DEG C measure relative density 1.12 ~ 1.16, let cool, adding ethanol makes alcohol content be 50%, leave standstill, filter, filtrate and above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, the alcohol liquid of Fructus Schisandrae Chinensis merges, decompression recycling ethanol, pressure is-0.08Mpa, temperature is 45-75 DEG C, be concentrated into 50 DEG C and measure relative density 1.12 ~ 1.16,
The Cortex Eucommiae is separately decocted, decoct with water secondary, add water 80-200 weight portion for the first time, decocts 1-3 hour, add water 80-150 weight portion for the second time, decoct 0.5-2 hour, collecting decoction, filter, concentrating under reduced pressure, pressure is-0.08Mpa, and temperature is 45-75 DEG C, is concentrated into the clear paste that 50 DEG C measure relative density 1.12 ~ 1.16, let cool, adding ethanol makes alcohol content be 50%, leaves standstill, and filters, decompression filtrate recycling ethanol, pressure is-0.08Mpa, and temperature is 45-75 DEG C, is concentrated into 50 DEG C and measures relative density 1.12 ~ 1.16;
Merged by above-mentioned concentrated solution, stir evenly, mesh screen filters, concentrated, adds above-mentioned Rhizoma Chuanxiong, Fructus Gardeniae, Herba Dendrobii, Fructus Schisandrae Chinensis clathrate, dextrin and aspartame, and mixing is granulated, and dry, granulate, to obtain final product.
3. the preparation method of Chinese medicine composition according to claim 2, it is characterized in that, described Chinese medicine composition is granule, tablet or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410422325.9A CN104147381B (en) | 2014-08-25 | 2014-08-25 | Traditional Chinese medicine composition for treating hypertension and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410422325.9A CN104147381B (en) | 2014-08-25 | 2014-08-25 | Traditional Chinese medicine composition for treating hypertension and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104147381A CN104147381A (en) | 2014-11-19 |
| CN104147381B true CN104147381B (en) | 2015-04-22 |
Family
ID=51873145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410422325.9A Expired - Fee Related CN104147381B (en) | 2014-08-25 | 2014-08-25 | Traditional Chinese medicine composition for treating hypertension and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104147381B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105078107A (en) * | 2015-09-08 | 2015-11-25 | 贵州盛世保康茶开发有限公司 | Pressure-reducing medicine pillow of Miao nationality |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103536690A (en) * | 2013-10-08 | 2014-01-29 | 覃祖仁 | Traditional Chinese medicine oral liquid for reducing blood pressure |
-
2014
- 2014-08-25 CN CN201410422325.9A patent/CN104147381B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103536690A (en) * | 2013-10-08 | 2014-01-29 | 覃祖仁 | Traditional Chinese medicine oral liquid for reducing blood pressure |
Non-Patent Citations (2)
| Title |
|---|
| 中医药治疗高血压病的研究概况;刘福明等;《湖北中医杂志》;20010810;第23卷(第08期);51-52 * |
| 柳叶治高血压;《农家科技》;19970228(第02期);9 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104147381A (en) | 2014-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
| CN103405728B (en) | A traditional Chinese medicine composition for treating climacteric syndrome and its preparation method | |
| CN103223111B (en) | Traditional Chinese medicine composition for treating diabetic nephropathy and preparation method thereof | |
| CN103690784B (en) | The Chinese medicine composition for the treatment of Complicating with Hypentersion nephropathy and preparation method | |
| CN108853342A (en) | A kind of Chinese medical extract that treating diabetes and preparation method | |
| CN106822585A (en) | Traditional Chinese medicine health-care preparation capable of nourishing yin and strengthening yang, invigorating the middle and replenishing qi, and preparation method thereof | |
| CN103611021B (en) | Be used for the treatment of medicine of Vesica sus domestica inflammation and preparation method thereof | |
| CN104147381B (en) | Traditional Chinese medicine composition for treating hypertension and preparation method thereof | |
| CN106860814B (en) | Health food composition for improving female frequent micturition and urinary incontinence and preparation method and application thereof | |
| CN104873926A (en) | Traditional Chinese medicine preparation for treating diarrhea as well as preparation method and application of traditional Chinese medicine preparation | |
| CN105362674A (en) | Traditional Chinese medicine used for treating diabetes and preparation method thereof | |
| CN104606570A (en) | Consumptive thirst tea substitute drink suitable for diabetes patients and preparation method of consumptive thirst tea substitute drink | |
| CN104547494A (en) | Traditional Chinese medicine composition medicinal liquor for treating hyperthyroidism and preparation process | |
| CN105012743A (en) | Health maintaining congee with antihypertensive effect | |
| CN104173973A (en) | Oral liquid for treating dysentery and preparation method of oral liquid | |
| CN117244021B (en) | A Chinese medicinal composition extract for reducing blood sugar, blood lipid, blood pressure and uric acid, and its preparation method | |
| CN108042744A (en) | A kind of Chinese medicine composition and preparation method for being used to treat prostatic disorders | |
| CN106266427A (en) | A kind of Traditional Chinese medicinal liquor treating nephropathy and preparation method thereof | |
| CN105381225A (en) | Traditional Chinese medicine composition for treating diabetes and preparation method thereof | |
| CN105456704A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN105106781A (en) | Traditional Chinese medicine for treating halitosis | |
| CN105412706A (en) | Traditional Chinese medicine composition for treating female endocrine dyscrasia | |
| CN118021901A (en) | Kidney-tonifying traditional Chinese medicine composition | |
| CN111803612A (en) | Traditional Chinese medicine composition for enhancing blood circulation and traditional Chinese medicine preparation | |
| CN105169277A (en) | Fructus gardeniae oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: CAO RONGFANG Free format text: FORMER OWNER: WANG SHENJIAN Effective date: 20150327 |
|
| C14 | Grant of patent or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Cao Rongfang Inventor before: Wang Shenjian |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG SHENJIAN TO: CAO RONGFANG Free format text: CORRECT: ADDRESS; FROM: 276017 LINYI, SHANDONG PROVINCE TO: 277700 LINYI, SHANDONG PROVINCE |
|
| GR01 | Patent grant | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20150327 Address after: 277700 Shandong Lanling County of Linyi Province Chengguan health Street No. 4 Building 1 unit 102 room 2 Applicant after: Cao Rongfang Address before: 276017 Luozhuang Province, Linyi District, Zhao Zhao Road, No. 1072 Applicant before: Wang Shenjian |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liu Ruiquan Inventor after: Han Feng Inventor before: Cao Rongfang |
|
| COR | Change of bibliographic data | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20161201 Address after: 262100 No. 315 Qingyun Mountain Road, Weifang, Shandong, Anqiu Patentee after: Liu Ruiquan Patentee after: Yang Wenwen Address before: 277700 Shandong Lanling County of Linyi Province Chengguan health Street No. 4 Building 1 unit 102 room 2 Patentee before: Cao Rongfang |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150422 Termination date: 20170825 |